Jubilant Pharmova Limited has informed the Exchange about General Updates
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Smallcap 250 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Pharmova has received an order from the Income Tax Department (DCIT/ACIT Central, Moradabad) for FY 2020 raising a tax demand of Rs. 22.10 crores. The demand reportedly arises from arithmetical errors, certain expense disallowances, deduction issues, and transfer pricing adjustments. The company has stated the order contains mistakes apparent from records and ignored the company's submissions. The company plans to file a rectification application with the Assessing Officer and/or appeal before the Income Tax Appellate Tribunal (ITAT). The company has stated it does not anticipate any material financial implications, as it expects relief through the redressal process.
This is a contested tax demand rather than an admitted liability, so the immediate impact on shareholders should be limited. Investors should monitor the outcome of the rectification/appeal, as a final adverse ruling could affect future earnings, though the company has expressed confidence in getting relief.